San Francisco, CA, United States of America

Mark Baer

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2015)
  • San Francisco, CA (US) (2011 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Mark Baer in Influenza Vaccine Development

Introduction: Mark Baer, an esteemed inventor based in San Francisco, CA, has made significant contributions to the field of vaccine development. With a total of seven patents to his name, his work primarily focuses on the production of flu vaccines, leveraging cutting-edge biotechnology to improve health outcomes for individuals susceptible to influenza virus infections.

Latest Patents: Among Mark Baer's most notable innovations are his latest patents, which include the production of flu vaccines through recombinant expression of influenza virus surface proteins in the fungus strain C1. These recombinant proteins are designed for use in influenza vaccine compositions, enhancing the efficacy and safety of immunization strategies. In addition, he has developed M1 polypeptides that can serve as vaccines and antigens, facilitating the generation of anti-M1 polypeptide antibodies. This approach aims to deliver prophylactic treatments for individuals prone to influenza virus infections, including immune-suppressed individuals who may not produce effective antibody responses.

Career Highlights: Mark Baer's career includes pivotal roles at several biotechnology firms, most notably Kalobios Pharmaceuticals, Inc. and Engen Bio, Inc. His innovative work has garnered recognition in both academic and professional settings, showcasing his ability to translate complex scientific concepts into practical solutions for public health.

Collaborations: Throughout his career, Mark has collaborated with notable professionals such as Geoffrey T. Yarranton and Christopher Robert Bebbington. These partnerships have enriched his research and contributed to advancements in vaccine technology.

Conclusion: Mark Baer's contributions to influenza vaccine development underscore his role as a leading inventor in the biotechnology space. Through his innovative patents and collaborations, he continues to make strides in improving vaccine efficacy and accessibility, paving the way for better health solutions in the fight against influenza. His work exemplifies the intersection of scientific inquiry and practical application, marking him as a significant figure in the field of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…